0.00Open0.00Pre Close0 Volume0 Open Interest21.00Strike Price0.00Turnover149.83%IV-22.81%PremiumDec 20, 2024Expiry Date3.90Intrinsic Value100Multiplier7DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8022Delta0.0763Gamma4.02Leverage Ratio-0.0665Theta-0.0032Rho-3.23Eff Leverage0.0068Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet